Global Shotgun Metagenomics Clinical Reporting Market Report 2026 | Capitalize on 16.7% CAGR as Illumina, Karius, QIAGEN and Oxford Nanopore Accelerate AI Diagnostics
Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Shotgun Metagenomics Clinical Reporting Market Global Report 2026" has been added to ResearchAndMarkets.com's offering.
The global shotgun metagenomics clinical reporting market is experiencing rapid growth as healthcare organizations increase their use of advanced genomic testing for infectious disease diagnosis. The market is projected to grow from $1.58 billion in 2025 to $1.83 billion in 2026, representing a compound annual growth rate (CAGR) of 16.4%.
Historical market growth has been supported by advances in next-generation sequencing technologies, increased demand for diagnostics during infectious disease outbreaks, and greater funding for microbiology and clinical genomics research. The expansion of molecular testing infrastructure within hospital laboratories and growing awareness of the need to monitor antimicrobial resistance have also accelerated the adoption of shotgun metagenomics clinical reporting.
The market is forecast to reach $3.4 billion by 2030, expanding at a CAGR of 16.7%. Key growth drivers include the wider adoption of precision medicine and personalized diagnostics, increasing use of artificial intelligence in genomic data interpretation, and the development of decentralized and point-of-care sequencing systems. Demand is also rising for rapid pathogen detection in critical care environments and for cloud-based bioinformatics platforms that can support efficient clinical workflows.
Prominent shotgun metagenomics clinical reporting market trends include AI-powered pathogen detection, automated clinical interpretation, cloud-based genomic data sharing, and ultra-rapid sequencing for point-of-care infectious disease testing. Integrated genomic analytics for antimicrobial resistance prediction and decentralized sequencing systems for hospital-based metagenomic testing are also expected to shape market development through 2030.
The increasing prevalence of infectious diseases is a major factor driving market expansion. Greater global connectivity and population movement have contributed to more frequent disease outbreaks, creating demand for faster and more comprehensive diagnostic methods. Shotgun metagenomics clinical reporting can identify pathogens, antimicrobial resistance markers, and co-infections directly from clinical samples, helping healthcare providers make more accurate diagnoses and select targeted treatments.
According to the World Health Organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, compared with 7.5 million in 2022. This increase of about 9.3% highlights the continuing burden of infectious diseases and the need for advanced clinical diagnostic technologies capable of supporting timely treatment decisions.
Innovation within the market is increasingly focused on respiratory genomic testing and the analysis of microbial cell-free DNA from clinical fluids. In April 2025, Karius Inc. launched Karius Focus BAL, a metagenomic sequencing test that analyzes bronchoalveolar lavage fluid. The test is designed to identify more than 500 pathogens and deliver processed diagnostic results within one calendar day after sample receipt. It also detected 50% more causes of infectious pneumonia than conventional testing approaches, demonstrating the potential value of advanced metagenomic diagnostics for vulnerable patient populations.
Strategic partnerships are also helping expand access to infectious disease testing. In April 2026, Karius Inc. partnered with Mayo Clinic Laboratories to make the Karius Spectrum and Karius Focus | BAL tests available for ordering through Mayo Clinic Laboratories. The collaboration is intended to improve access to comprehensive pathogen detection and clinical reporting while supporting broader adoption of advanced metagenomic testing.
North America dominated the shotgun metagenomics clinical reporting market in 2025, supported by established healthcare infrastructure, genomic research capabilities, and the early adoption of advanced molecular diagnostics. Asia-Pacific is expected to be the fastest-growing region during the forecast period. Regions covered by the market analysis include Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Countries covered in the shotgun metagenomics clinical reporting market analysis include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
Markets Covered:
1) By Product Type: Software; Services
2) By Sample Type: Blood Samples; Stool Samples; Respiratory Samples; Cerebrospinal Fluid Samples; Tissue Biopsy Samples; Urine Samples; Other Body Fluid Samples
3) By Sequencing Technology Type: Short Read Sequencing; Long Read Sequencing; Hybrid Sequencing
4) By Application Type: Infectious Disease Diagnostics; Oncology; Microbiome Analysis; Antimicrobial Resistance; Other Application Types
5) By End User Type: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End User Types
Subsegments:
1) By Software: Data Analysis And Processing Software; Pathogen Identification Databases; Clinical Report Generation Platforms; Antimicrobial Resistance Profiling Software
2) By Services: End To End Genomic Diagnostic Services; Sample Processing And Next Generation Sequencing Services; Bioinformatics Analysis Services; Clinical Interpretation And Reporting Services
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/2gvq5t
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.